719.39
price down icon0.80%   -5.83
after-market Dopo l'orario di chiusura: 723.00 3.61 +0.50%
loading
Precedente Chiudi:
$725.22
Aprire:
$725.22
Volume 24 ore:
2.93M
Relative Volume:
0.73
Capitalizzazione di mercato:
$681.79B
Reddito:
$49.00B
Utile/perdita netta:
$11.11B
Rapporto P/E:
58.53
EPS:
12.29
Flusso di cassa netto:
$-1.27B
1 W Prestazione:
-0.77%
1M Prestazione:
-18.00%
6M Prestazione:
-8.73%
1 anno Prestazione:
-10.95%
Intervallo 1D:
Value
$714.74
$729.99
Intervallo di 1 settimana:
Value
$709.00
$731.31
Portata 52W:
Value
$677.09
$972.53

Lilly Eli Co Stock (LLY) Company Profile

Name
Nome
Lilly Eli Co
Name
Telefono
(317) 276-2000
Name
Indirizzo
LILLY CORPORATE CTR, INDIANAPOLIS, IN
Name
Dipendente
47,000
Name
Cinguettio
@LillyPad
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
LLY's Discussions on Twitter

Confronta LLY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
LLY
Lilly Eli Co
719.39 670.62B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
152.43 368.56B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
183.09 321.13B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
111.87 222.75B 53.22B 12.86B 14.85B 6.39
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
68.60 303.04B 43.59B 15.04B 10.74B 3.3766

Lilly Eli Co Stock (LLY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-28 Downgrade HSBC Securities Buy → Reduce
2025-04-22 Iniziato Cantor Fitzgerald Overweight
2024-12-10 Ripresa BofA Securities Buy
2024-11-15 Iniziato Wolfe Research Outperform
2024-10-17 Iniziato Bernstein Outperform
2024-09-13 Ripresa Citigroup Buy
2024-08-12 Aggiornamento Deutsche Bank Hold → Buy
2024-02-21 Downgrade DZ Bank Buy → Hold
2024-02-16 Reiterato Morgan Stanley Overweight
2023-12-21 Downgrade Daiwa Securities Buy → Outperform
2023-11-09 Iniziato Deutsche Bank Hold
2023-10-20 Ripresa UBS Buy
2023-08-09 Aggiornamento Jefferies Hold → Buy
2023-07-26 Reiterato Citigroup Buy
2023-07-14 Iniziato HSBC Securities Buy
2023-05-24 Reiterato BofA Securities Buy
2023-05-24 Reiterato UBS Buy
2023-03-13 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-03-06 Iniziato Jefferies Hold
2023-02-15 Downgrade Societe Generale Hold → Sell
2022-11-18 Iniziato Credit Suisse Outperform
2022-09-22 Aggiornamento UBS Neutral → Buy
2022-05-23 Iniziato SVB Leerink Outperform
2022-04-06 Ripresa Morgan Stanley Overweight
2022-03-10 Iniziato Daiwa Securities Outperform
2022-01-21 Aggiornamento DZ Bank Hold → Buy
2022-01-03 Reiterato Bernstein Mkt Perform
2021-12-17 Iniziato Goldman Neutral
2021-12-16 Reiterato BMO Capital Markets Outperform
2021-12-16 Reiterato BofA Securities Buy
2021-12-09 Ripresa Wells Fargo Equal Weight
2021-11-19 Iniziato BMO Capital Markets Outperform
2021-10-11 Aggiornamento Berenberg Hold → Buy
2021-09-29 Aggiornamento Citigroup Neutral → Buy
2021-08-05 Aggiornamento DZ Bank Hold → Buy
2021-07-27 Ripresa Truist Buy
2021-06-24 Reiterato Cantor Fitzgerald Overweight
2021-01-19 Aggiornamento Mizuho Neutral → Buy
2020-12-10 Aggiornamento Wolfe Research Peer Perform → Outperform
2020-11-10 Ripresa Bernstein Mkt Perform
2020-09-29 Iniziato Berenberg Hold
2020-09-03 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-06-16 Aggiornamento Guggenheim Neutral → Buy
2020-04-21 Downgrade UBS Buy → Neutral
2020-04-09 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-02-06 Iniziato Mizuho Neutral
2019-12-18 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2019-10-17 Ripresa BofA/Merrill Buy
2019-05-28 Iniziato Goldman Buy
2019-04-24 Aggiornamento Edward Jones Hold → Buy
2019-04-11 Downgrade Guggenheim Buy → Neutral
2019-03-12 Iniziato JP Morgan Overweight
2019-01-23 Iniziato UBS Buy
2018-11-26 Downgrade Citigroup Buy → Neutral
2018-10-31 Aggiornamento Credit Suisse Underperform → Neutral
2018-10-09 Iniziato Guggenheim Buy
2018-10-01 Reiterato SunTrust Buy
2018-09-26 Ripresa JP Morgan Overweight
Mostra tutto

Lilly Eli Co Borsa (LLY) Ultime notizie

pulisher
11:27 AM

Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer - TradingView

11:27 AM
pulisher
10:37 AM

BMO reiterates Eli Lilly stock with $900 target on SiteOne deal - Investing.com

10:37 AM
pulisher
10:36 AM

Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy? - The Globe and Mail

10:36 AM
pulisher
10:07 AM

Lilly seeks to expand pain pipeline with $1B acquisition - dailyjournal.net

10:07 AM
pulisher
09:39 AM

Lilly to acquire biotech developing pain drugs - statnews.com

09:39 AM
pulisher
09:30 AM

Reports: Lilly eyes Houston for new $5.9B manufacturing facility - Indianapolis Business Journal

09:30 AM
pulisher
05:32 AM

Lilly to acquire SiteOne Therapeutics to expand pain pipeline - World Pharmaceutical Frontiers

05:32 AM
pulisher
04:40 AM

Eli Lilly to expand pain portfolio with SiteOne acquisition - Cleanroom Technology

04:40 AM
pulisher
04:15 AM

Novo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market? - The Motley Fool

04:15 AM
pulisher
May 27, 2025

Jim Cramer Notes Eli Lilly (LLY) Stock is at a “Decent Level to Start a Position” - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

Lilly snags Peninsula non-opioid pain drug company for up to $1 billion - The Business Journals

May 27, 2025
pulisher
May 27, 2025

Eli Lilly Commits $1B to Get Drug That Could Rival Vertex’s New Non-Opioid Pain Med - MedCity News

May 27, 2025
pulisher
May 27, 2025

Lilly's Acquisition Of SiteOne Aims For Opioid AlternativesEli Lilly (NYSE:LLY) - Benzinga

May 27, 2025
pulisher
May 27, 2025

Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics Acquisition - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

Eli Lilly Inks $1B Deal For Non-Opioid Pain-Drug Maker - Law360

May 27, 2025
pulisher
May 27, 2025

Eli Lilly (LLY) Shows Strong Options Activity Amid Share Price Rise | LLY Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Eli Lilly to expand pain pipeline with $1bn SiteOne buyout - Pharmaceutical Technology

May 27, 2025
pulisher
May 27, 2025

Eli Lilly to buy SiteOne for $1 billion with eye on non-opioid pain drug - Reuters

May 27, 2025
pulisher
May 27, 2025

Eli Lilly’s Strategic Acquisition of SiteOne Therapeutics Bolsters Pain Management Portfolio and Supports Buy Rating - TipRanks

May 27, 2025
pulisher
May 27, 2025

Eli Lilly (LLY) Expands into Pain Management Through Acquisition | LLY Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Eli Lilly (LLY) to Acquire SiteOne Therapeutics for $1 Billion - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Eli Lilly expands neuroscience pipeline with $1B SiteOne acquisition - Proactive financial news

May 27, 2025
pulisher
May 27, 2025

Seven top pharmas posted revenue declines in Q1. The common thread? All are US firms - Fierce Pharma

May 27, 2025
pulisher
May 27, 2025

Eli Lilly To Acquire SiteOne Therapeutics For Up To $1B To Advance Pain Management Pipeline: But Retail’s Unconvinced By Stocktwits - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Lilly to acquire SiteOne, enhancing non-opioid pain treatment options By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Lilly to acquire SiteOne, enhancing non-opioid pain treatment options - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics By Investing.com - Investing.com Nigeria

May 27, 2025
pulisher
May 27, 2025

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics - Investing.com

May 27, 2025
pulisher
May 27, 2025

Eli Lilly (LLY) to Acquire SiteOne Therapeutics in $1 Billion De - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Eli Lilly’s SWOT analysis: stock poised for growth amid challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Eli Lilly to acquire privately held SiteOne - Yahoo

May 27, 2025
pulisher
May 27, 2025

Eli Lilly & Co. (LLY) Acquires SiteOne Therapeutics - StreetInsider

May 27, 2025
pulisher
May 27, 2025

Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics - Eli Lilly and Company

May 27, 2025
pulisher
May 27, 2025

Lilly Makes $1B Bet on Next-Generation Pain Treatment: Key Details of SiteOne Acquisition Revealed - Stock Titan

May 27, 2025
pulisher
May 27, 2025

Investment Case For Eli Lilly Still Weak, Despite Novo Nordisk's Struggle (NYSE:LLY) - Seeking Alpha

May 27, 2025
pulisher
May 27, 2025

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

May 27, 2025
pulisher
May 27, 2025

Lilly's blood drive breaks site record - reporter.net

May 27, 2025
pulisher
May 27, 2025

Here's How the Pharmaceutical Import Tariffs Could Affect Eli Lilly - aol.com

May 27, 2025
pulisher
May 26, 2025

Eli Lilly (LLY) Considers New $5.9 Billion Plant in Houston, Texas - TipRanks

May 26, 2025
pulisher
May 26, 2025

Prurigo Nodularis Market - GlobeNewswire Inc.

May 26, 2025
pulisher
May 25, 2025

Eli Lilly (LLY) Faces Lowered Market Forecast for Anti-Obesity D - GuruFocus

May 25, 2025
pulisher
May 24, 2025

Eli Lilly & Co (LLY) Gets a Buy from Bank of America Securities - The Globe and Mail

May 24, 2025
pulisher
May 23, 2025

Is Eli Lilly Stock A Sell After Novo Nordisk Wins An Unexpected Obesity Edge? - Investor's Business Daily

May 23, 2025
pulisher
May 23, 2025

Type 2 Diabetes Market to Expand Significantly by 2034, States DelveInsight Report | Eli Lilly and Company, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

With short film, Eli Lilly is Seeking to transform itself as a drugmaker - PR Week

May 23, 2025
pulisher
May 23, 2025

The Zacks Analyst Blog Highlights Eli Lilly, GE Aerospace and Amgen - Yahoo Finance

May 23, 2025
pulisher
May 22, 2025

Eli Lilly and Company (LLY) Gains Approval in Australia for Early Alzheimer’s Treatment - Insider Monkey

May 22, 2025
pulisher
May 22, 2025

Eli Lilly & Co. (LLY) gives presentation highlights for 2025 ASCO - StreetInsider

May 22, 2025
pulisher
May 22, 2025

Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

ELI LILLY AND COMPANY (LLY) - MSN

May 22, 2025
pulisher
May 22, 2025

Morgan Stanley Reiterates Buy Rating on Eli Lilly Stock (LLY), Citing New Copay Strategy - TipRanks

May 22, 2025

Lilly Eli Co Azioni (LLY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general JNJ
$152.43
price down icon 0.54%
$183.09
price down icon 1.42%
drug_manufacturers_general NVS
$111.87
price down icon 1.18%
drug_manufacturers_general NVO
$68.60
price down icon 2.61%
drug_manufacturers_general MRK
$76.17
price down icon 1.83%
Capitalizzazione:     |  Volume (24 ore):